Amissa Information

Amissa makes menopause care measurable, scalable, and properly reimbursed. Menopause affects 75 million women in the U.S. — yet only 7% of OB/GYNs feel adequately trained to treat it, and symptoms are still buried in unstructured visit notes with no standard way to measure or track overtime. Amissa is the clinical infrastructure layer that changes that. We turn patient-reported symptoms and wearable data into structured, longitudinal insight that fits directly into existing clinical workflows — no new hardware, no EHR replacement, no added patient burden. By the time the patient walks in, clinicians have trended severity scores, wearable-correlated data, and billing-ready documentation — without writing a single extra chart note. The result: less clinician cognitive load, defensible E/M coding, faster treatment titration, and measurable patient outcomes. NIH-backed and live in practice today, Amissa is building the only structured longitudinal dataset on midlife women — making us infrastructure for the AI era of women's health, not a casualty of it. We work with forward-thinking OB/GYNs, menopause specialists, and health systems ready to deliver menopause care that's measurable, scalable, and properly reimbursed.